1. Pink Sheet
  2. >>Agency Leadership

FDA Disruption: If Trump Wins, Could Big Changes Be Coming?

 
• By Ramsey Baghdadi

The agency is clearly on the radar of former President Trump and his new coterie of tech moguls.

disruption
Would Donald Trump choose a break-the-mold or middle-of-the-road FDA commissioner? • Source: Shutterstock

Underground tunnels.

That is where the conversation began between Twitter/X CEO Elon Musk and former President Donald Trump before moving to reforming...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Agency Leadership

More from Pink Sheet

Recent And Upcoming FDA Advisory Committee Meetings

 
• By Sue Sutter

Recent and upcoming US FDA advisory committee meetings and a summary of the topics covered.

UK-Wide Strategy Needed To Move Clinical Trial Diversity Plans To Next Stage

 
• By Vibha Sharma

The UK’s research-based pharma industry and medical research charities have set out clear action points to drive greater diversity and inclusion in clinical trials.

Blenrep’s Comeback Continues As England Becomes First To Fund Drug

 
• By Eliza Slawther

Blenrep, GSK’s multiple myeloma therapy, faced a major setback when it was withdrawn from the market in 2022. The drug has since made a return as a second-line therapy, and is on track to being reimbursed in England.